News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Biotech/Pharma - Patent News
Neurana Pharma Receives Notice Of Allowance Of Patents For Tolperisone, A Novel Skeletal Muscle Relaxant 5/26/2017
SurGenTec’s GRAFTGUN Receives Key Patent 5/26/2017
Creative Medical Technology Files Patent On AmnioStem Mediated Immune Reprogramming For Stroke 5/25/2017
Diba Industries, Inc. Announces Issuance Of U.S. Patent For Multistage Syringe Assembly 5/25/2017
Ammonett Pharma Receives Notice Of Allowance Of U.S. Patent For Oratrope Related To Detecting And Treating Growth Hormone Deficiency 5/25/2017
Intec Pharma Granted U.S. Patent For Accordion Pill Comprising Levodopa For Improved Treatment Of Parkinson's Diseases Symptoms 5/24/2017
Great Basin Scientific Issued Second U.S. Patent For PCR Amplification Suppressor 5/24/2017
Regeneus (RGS.AX) Japanese Patent Office To Grant Key Patent For Progenza 5/24/2017
GB Sciences Files Patent Application For Chronic Pain And Heart Therapies 5/23/2017
DSM Sinochem Pharma Wins Indian Patent Infringement Case Against Sinopharm Weiqida Pharmaceutical 5/23/2017
Resverlogix (RVX.TO) Release: Recent Publication And Patent Application Referencing Apabetalone Support Its Continued Development And Success 5/23/2017
Helius Medical Technologies Receives First Of Two Human Performance Patents 5/23/2017
Origenis Announces Patent Grants For Lead Small Molecule LRRK2 Inhibitors For Treatment Of Neurodegenerative And Inflammatory Diseases 5/23/2017
Herantis Pharma Granted A U.S. Patent On Therapeutic Use Of MANF 5/23/2017
Biocept (BIOC) Awarded U.S. Patent With Broad Claims For Antibody Capture Of Targets Of Interest On Any Solid Surface Including Ctcs And Other Materials Shed By Solid Tumors Into Blood 5/22/2017
Avenue Therapeutics Receives Notice Of Allowance For A New Patent Application Covering Methods Of Administration For Intravenous Tramadol 5/19/2017
Why This Humira Patent Loss Might Not Be What You Think 5/18/2017
CURE Pharma Announces Crosslink Patent For Covering Company’s Proprietary Curefilm Drug Delivery Technology 5/18/2017
NEMUS Bioscience Reports Prodrug Of Tetrahydrocannabinol (THC) Issued Patent Coverage In Canada And Hong Kong 5/18/2017
Visionsense Files For An Inter Partes Review (IPR) Against Novadaq Technologies, Inc.'s U.S. Patent 8,892,190 5/17/2017
Statement By ResMed (RMD) On Plans To Renew Its Patent Infringement Case Against Fisher & Paykel 5/17/2017
Coherus Prevails In ‘135 IPR Decision 5/17/2017
Axis Biotec Innovative Wound Dressing’s IP Issued In Germany 5/17/2017
Vedanta Biosciences Granted Three U.S. Patents Broadly Covering Pharmaceutical Compositions And Methods Of Use For Therapeutics Based On Immune-Modulating Bacterial Consortia 5/16/2017
Synaffix Secures End-to-End Patent Protection Of Its ADC Technology Platform As Its HydraSpace Patent Grants In The United States 5/16/2017
Albireo (ALBO) Announces Two New U.S. Patents Allowed For A4250 With Term Into 2031 5/16/2017
Struggling XBiotech (XBIT) Quietly Discloses Exec Resignation 5/15/2017
Nuvo Pharma Announces District Court Decision To Uphold U.S. Pennsaid 2% Patent 5/15/2017
Glactone Granted Patent For STAT3 Inhibitors 5/15/2017
Progenra, Inc. Receives Second Immune Oncology Patent 5/11/2017
Avita Medical Initiates Legal Proceedings To Cancel Renovacare Patent 5/11/2017
Calyxt Patent Encompassing Broad Uses Of Plant Gene Editing Technologies Maintained By USPTO 5/11/2017
Cellectis (CLLS) Patent Encompassing Broad Uses Of Gene Editing Technologies Maintained By USPTO 5/11/2017
InMed Files Provisional Patent Application For Ophthalmic Drug Delivery 5/11/2017
Caribou Biosciences Announces Grant Of A Key CRISPR-Cas9 Genome Editing Patent In Europe 5/10/2017
Onxeo Announces Allowance Of U.S. Patent For Livatag In Hepatocellular Carcinoma 5/10/2017
NEMUS Bioscience Reports Prodrug Of Tetrahydrocannabinol (THC) Receives Second Patent Issued In The United States Related To Proprietary Delivery Mechanisms For Treatment Of Glaucoma 5/10/2017
Oramed (ORMP) Granted Canadian Patent For GLP-1 Analog Capsule 5/9/2017
Soligenix (SNGX) Receives Japanese Patent For ThermoVax Vaccine Heat Stabilization Platform Technology 5/9/2017
Pulmatrix (PULM) Receives Key US. Patent For Its Inhaled Drug For COPD 5/9/2017
Visualant Granted Biological Tissue Patent 5/9/2017
AgriLabs, Ltd. Release: Broad Patent Granted for ENABL Adjuvant Technology 5/9/2017
AVEO Oncology (AVEO) Announces Receipt Of USPTO Notice Of Allowance Related To AV-353 5/8/2017
Ocugen, Inc. Expands Global Patent Portfolio For OCU200 5/8/2017
Savara Announces Issuance Of U.S. Composition Of Matter Patent Covering AeroVanc 5/8/2017
Almac Discovery Announce Key Wee-1 Kinase Patent Approval 5/8/2017
Key Patent Issues Covering Protagonist (PTGX)' Oral Peptide IL-23 Receptor Antagonists, Including The Development Candidate PTG-200 5/5/2017
Cleveland HeartLab LLC Adds Two Additional Patents To Its Extensive Intellectual Property Position For The Myeloperoxidase (MPO) Test, A Key Predictor Of Major Cardiac Events 5/4/2017
Stainwei Granted U.S. Patent For Anti-VEGF Monoclonal Antibody And Its Anti-PD-1 Mab Demonstrating Prolonged Anti-Tumor Activity In Pre-Clinical Studies 5/3/2017
Ritter Pharma Announces Issuance Of New Patents For Its Lactose Intolerance Treatment, RP-G28, And Provides An Update On Its Path Forward Into Phase III 5/3/2017
bluebird bio (BLUE) Licenses Lentiviral Vector Patent Rights For Development And Commercialization Of Cell Therapies 5/2/2017
bluebird bio (BLUE) Enters Lentiviral Vector Patent License Agreement With GlaxoSmithKline (GSK) For Commercialization Of Gene Therapies 5/2/2017
Tonix Pharma (TNXP) Announces Issuance Of U.S. Patent For Tnx-102 Sl Composition And Formulation: Designed For Transmucosal Absorption And Bedtime Daily Use 5/2/2017
SteadyMed (STDY) Receives USPTO Notice Of Allowance For Patent Related To Key Patchpump Technology 5/2/2017
Celyad Grants To Novartis AG (NVS) A Non-Exclusive License For Its Allogeneic TCR-Deficient CAR-T Cells Patents 5/2/2017
Caribou Biosciences Announces Grant Of A Key CRISPR-Cas9 Patent In The U.S. 5/2/2017
ReForm Biologics Announces Issuance Of U.S. Patent For New Excipient To Improve Antibody-Based Therapeutics 5/1/2017
CEL-SCI (CVM) Receives Intent To Grant Notice For New Multikine Patent From The European Patent Office 4/28/2017
Providence Medical Technology Announces Issuance Of Four Additional U.S. Patents 4/27/2017
SpinalCyte, LLC Receives New Australian Patent 4/27/2017
ArQule (ARQL) Announces Issuance Of U.S. Patent Covering Composition Of Matter Of Proprietary Reversible BTK Inhibitor, ARQ 531 4/26/2017
Out Of Silicon Valley, A Billion-Dollar Orthodontics Business Built With Plastic And Patents 4/26/2017
Intellia And CRISPR (CRSP) Announce U.S. Patent Covering CRISPR/Cas9 Ribonucleoprotein Complexes 4/26/2017
Aclaris (ACRS) Announces Notice Of Allowance For A U.S. Patent Application Covering Lead Candidate A-101 Topical Solution 4/26/2017
Asuragen, Inc. Strengthens Repetitive Sequence And Short Structural Variant Intellectual Property Portfolio 4/25/2017
United States Patent Issued To Replicel Life Sciences For Its Novel Dermal Injection Technologies 4/25/2017
MPEG LA Invites CRISPR-Cas9 Patents To Be Pooled In A One-Stop License 4/25/2017
Galectin (GALT) Receives Notice Of Japanese Decision To Grant A Composition Of Matter Patent For GR-MD-02 4/25/2017
Cellectar Biosciences  (CLRB) Receives Additional U.S. Patents For PDC Optical Agents In The Detection Of Multiple Cancers 4/25/2017
Coherus Completes Patent Dance Exchange With Amgen (AMGN) For Neulasta Biosimilar 4/25/2017
Mati Therapeutics Hits Major Milestone With 100 Patents 4/25/2017
Benevir Biopharm Granted Patent Protecting Lead Oncolytic Immunotherapy Stealth-1H And Other Platform Assets 4/25/2017
PDL BioPharma (PDLI) Announces Settlement Of Keytruda Patent Infringement Lawsuit With Merck & Co. (MRK) 4/24/2017
Acasti Pharma Granted Additional Composition & Use Patents In Taiwan And Australia; Safeguards Valuable Market Expansion Opportunities 4/24/2017
Mount Tam Biotechnologies Announces That The European Patent Office Has Allowed A Key Patent For Lead Compound TAM-01 4/24/2017
Oramed (ORMP) Granted European Patent For Combination Oral Insulin And GLP-1 Analog Capsule 4/20/2017
BioRestorative Receives Notice Of Acceptance For Key Metabolic Patent In Australia 4/20/2017
Argentum And Allergan (AGN) Settle Patent Dispute Over RESTASIS 4/19/2017
Egaceutical Corporation Demonstrates Human Age Reversal, Patent Is Pending 4/19/2017
Pluristem Therapeutics (PSTI) Reaches Milestone Of 100 Granted Patents, Including Coverage Of Leading Indications In Major Markets 4/19/2017
Spherix (SPEX) Announces Economic Interest Acquired In New Patent Portfolio 4/19/2017
EyeLock Receives Patent For Mobility Identity Platforms 4/19/2017
Kura Oncology Granted U.S. Patent For Clinical-Stage ERK Inhibitor, KO-947 4/19/2017
Spectro Scientific Wins Patent For Extending Lasernet Fines Particle Analysis Technology With Ferrous Particle Measurement Capability 4/19/2017
Biocept (BIOC) Awarded Additional Patent In Japan Expanding Intellectual Property Estate To 19 Issued Patents Protecting Its Target Selector Liquid Biopsy Platform 4/18/2017
Cellectar Biosciences  (CLRB) Receives Japanese Patent For CLR 131 And CLR 125 For The Treatment Of Cancer Stem Cells 4/18/2017
Santalis Announces Issuance Of An Australian Patent Covering The Use Of Sandalwood Oil To Treat Cancers 4/18/2017
RedHill Biopharma (RDHL) Receives Notice Of Allowance For Two Additional U.S. Patents Covering BEKINDA 4/18/2017
Repros Therapeutics (RPRX) Announces The Issuance Of New U.S. Patent Relating To Treatment Using Off Drug Intervals For Certain Uterine Conditions 4/17/2017
Helius Medical Technologies Receives Two Medical Method Patents 4/17/2017
LegoChem Biosciences Receives U.S. Patent For Its Own Proprietary ADC Platform Technology ConjuAll 4/17/2017
Incysus Granted European Patent Covering Its Drug Resistant Immunotherapy (DRI) Technology 4/13/2017
BioMarin (BMRN) Announces Kuvan (sapropterin dihydrochloride) Patent Challenge Settlement 4/13/2017
Innovus Pharma Receives Patent For Its Sensum+ Product In Morocco 4/12/2017
Synergy Pharma (SGYP) Announces Issuance Of Three New Patents Expected To Extend TRULANCE (Plecanatide) Patent Protection Until 2032 4/12/2017
Intellia Announces European Patent Office’s Decision to Grant CRISPR/Cas9 Genome Editing Technology Patent 4/11/2017
Hi-Tech Pharmacal (HITK) Wins Almost $1 Million In Legal Fees From Thermolife And Stanford University After Winning Major Patent Case 4/10/2017
Intellipharmaceutics (IPCI) Announces Patent Litigation By Purdue Pharma L.P. Against Its Rexista Abuse-Deterrent Extended-Release Oxycodone 4/10/2017
KFx Medical Announces Another And Third License Of Its Knotless Double Row Patents 4/7/2017
IBM (IBM) Patents Machine Learning Models For Drug Discovery 4/7/2017
Jazz Pharma (JAZZ) Reaches Settlement With Hikma (HIK.L) Related To Xyrem Patent Litigation 4/6/2017
APR Applied Pharma Research S.A. Wants To Make The Difference For PKU People Thanks To An Innovative And Patented Technology 4/6/2017
SpinalCyte, LLC Receives New European Patent 4/6/2017
Creative Medical Technology Files Patent On Reducing Radiation Toxicity Using AmnioStem Universal Donor Stem Cell Product 4/5/2017
Neothetics (NEOT) Announces Issuance By USPTO Of Eighth Patent Directed To LIPO-202 Lead Clinical Asset 4/5/2017
Varian Medical Systems (VAR) And Elekta Settle Patent Litigation 4/4/2017
AbbVie (ABBV) Accuses Novartis AG (NVS) Of Trying To Patent The Hep C Virus 4/4/2017
Patent Case Of Carl Zeiss Meditec AG (AFX.DE) And VSY Biotechnology B.V. 4/4/2017
Diffusion Pharma Awarded U.S. Patent For TSC As Therapeutic In Five Hypoxia-Related Indications 4/4/2017
Aclaris (ACRS) Announces Notice Of Allowance For Two U.S. Patent Applications Covering Baricitnib And Decernotinib, Respectively, For Hair Loss Disorders 4/4/2017
Interpace Diagnostics Announces European Patent Approval For Underlying Technology Of Its Thyramir Microrna Classifier 4/3/2017
ProQR Therapeutics B.V. (PRQR) Announces The Grant Of Two Key Patents, Protecting QR-010 For Cystic Fibrosis In The U.S. And EU 4/3/2017
Forward Pharma (FWP) Intends To Appeal Decision In Patent Interference Proceeding With Biogen (BIIB) 4/3/2017
United Therapeutics (UTHR) Announces Decision From Patent Trial And Appeal Board And Issuance Of New Patents 4/3/2017
Sunovion Announces Utibron Neohaler (Indacaterol/Glycopyrrolate) Inhalation Powder Now Available In The United States 4/3/2017
Cardiome Pharma Corp. (COM.TO)'s Partner SteadyMed Receives Favourable Ruling In Its USPTO Inter Partes Review 4/3/2017
Treos Bio Announces Filing Of Key Patent Applications On Its Precision Therapeutic Cancer Vaccine Development Platform And Its Compositions For Colorectal And Breast Cancers 4/3/2017
SteadyMed (STDY) Receives Favorable Ruling In Inter Partes Review Against United Therapeutics (UTHR) Patent 4/3/2017
BioDelivery (BDSI) Announces The Granting Of Two New Patents To Be Listed In FDA's Orange Book Further Extending And Strengthening Patent Protection On BELBUCA, BUNAVAIL And ONSOLIS 3/31/2017
IMPAX Labs (IPXL) Announces Favorable Ruling Regarding Patent Validity For Zomig (Zolmitriptan) Nasal Spray 3/31/2017
Acorda (ACOR) Release: U.S. District Court Issues Decision To Invalidate Four Ampyra Patents; Company Will Appeal Ruling 3/31/2017
Pivot Pharmaceuticals Announces Receipt Of Notice Of Allowance From The United States Patent And Trademark Office 3/30/2017
Immune Therapeutics Announces Expansion Of Patent Portfolio 3/30/2017
CortControl Granted U.S. Patent For Vaccine Immuno-Enhancement Treatment For At-Risk Global Populations 3/29/2017
Key BioTime (BTX) Patents Upheld By European Patent Office 3/28/2017
CytoSorbents Strengthens Intellectual Property Portfolio With New Patents Issued In The U.S., China, Japan, Russia, And Australia 3/28/2017
ERS Genomics Release: European Patent Office To Grant Broad Claims On Patent Covering CRISPR-Cas9 Gene Editing Technology 3/28/2017
RXi Pharma (RXII) Granted Patent In Japan For Lead Clinical Candidate RXI-109 3/28/2017
Propanc Receives Patentability Opinion For Method Of Treating Cancer Stem Cells 3/28/2017
Innovus Pharma Announces Receipt Of Notice Of Intention To Grant Sensum+ European Patent 3/27/2017
Xenetic Biosciences Provides Update On Patent Portfolio Development 3/27/2017
Argentum Persists In Challenging The "Evergreening" Patent On UCB, Inc. (UCBJF.PK)'s VIMPAT 3/24/2017
Mount Tam Biotechnologies Announces That The Japan Patent Office Has Allowed A Key Patent For Lead Compound TAM-01 3/24/2017
Biogen (BIIB)'s Victory Over $4 Billion MS Patent Spat Makes Company an Even More Attractive M&A Target 3/24/2017
Egalet Announces Issuance Of New U.S. And International Patents For Guardian Technology 3/23/2017
Ampio Pharmaceuticals, Inc. (AMPE) Updates Intellectual Property And Regulatory Exclusivity Strategy To Support The Commercialization Of Ampion 3/23/2017
USPTO Grants Composition Of Matter Patent To Achillion (ACHN) For Small Molecule Complement Alternative Pathway Factor D Inhibitors 3/22/2017
GILUPI Extends Its Patent Portfolio 3/22/2017
Eagle Pharma (EGRX) Announces Three New Patents Issued For Bendeka 3/21/2017
IGC Files Patent For Cannabis-Based Combination Therapy For Treatment Of Eating Disorders 3/21/2017
Pulmatrix (PULM) Receives European Patent For Its Inhaled Drug Delivery Technology 3/21/2017
Cellectar Biosciences  (CLRB) Further Deepens Intellectual Property Portfolio With Patent Grant For PET Imaging PDC 3/21/2017
Palatin Tech (PTN) Receives Notice Of Allowance On Bremelanotide Methods Of Use Patent For Treatment Of Hypoactive Sexual Desire Disorder In Premenopausal Women 3/20/2017
Edico Genome Expands Intellectual Property Portfolio With An Additional Five Patents Issued For DRAGEN Platform 3/20/2017
Almirall Release: Thermi Defends Against Viveve’s Claims Of Patent Infringement 3/17/2017
Vyripharm Biopharma Issued Patent For Comprehensive Medical Cannabis Testing From Agriculture To Clinical Applications 3/17/2017
USPTO Rejects New Reexamination Request Against Celyad’s US Patent For Production Of Allogeneic TCR-Deficient CAR-T Cells 3/16/2017
Kadimastem Granted A Patent In The US For Treatment Of Neurodegenerative Diseases 3/16/2017
Synpromics Granted Key Patent In Synthetic Promoter Development 3/16/2017
aTyr Pharma Announces Issuance Of U.S. Patent That Extends Patent Protection Of Physiocrines Derived From 20 Out Of 20 Human tRNA Synthetases 3/15/2017
Patents Licensed To Synthon Relating To The CD47-SIRPa Pathway Resist Challenges In The U.S. And Europe 3/15/2017
Cell Design Labs Announces Issuance Of Broad Patent For Programmable Car-T Cells To Treat Cancer And Other Diseases 3/15/2017
Resverlogix (RVX.TO) Announces Receipt Of Notice Of Allowance From The United States Patent And Trademark Office 3/15/2017
Cell Design Labs Announces Issuance Of Broad Patent For Programmable Car-T Cells To Treat Cancer And Other Diseases 3/15/2017
Mucodel Pharma Announces Patent Allowance For Mucodel’s Co-Gel Buccal Naloxone (Exonal™) 3/15/2017
Tonix Pharma (TNXP) Receives Notice Of Allowance For New U.S. Patent Covering Composition And Manufacture Of TNX-102 SL 3/14/2017
InDex Pharmaceuticals AB Gets Patent For Additional DIMS Compounds Granted In The U.S. 3/14/2017
Newly Issued Japanese Patent For PDC Optical Agents Further Strengthens Cellectar Biosciences  (CLRB)’ Intellectual Property Portfolio 3/14/2017
Cura Pharmaceutical Co., Inc. Announces U.S. Patent Allowances For Its Oral Thin Film Technology For Manufacture And Use In Pet Products 3/14/2017
Protalex (PRTX) Significantly Strengthens Global Intellectual Property Portfolio For Proprietary Immunomodulatory Therapeutic 3/13/2017
Acorda (ACOR) Release: Patent Trials And Appeal Board (PTAB) Upholds Four AMPYRA Patents 3/10/2017
Mersana Adds To Antibody Drug Conjugate (ADC) Intellectual Property Portfolio With Issuance Of EP Patent 3/9/2017
Edwards Lifesciences Corporation (EW) Release: German Patent Court Issues Initial Decision 3/9/2017
Novelion (AEGR) Release: U.S. Patent Trial And Appeal Board Affirms Lomitapide Patents With Favorable IPR Decisions 3/7/2017
Supernus (SUPN) Announces Settlement With Zydus Pharmaceuticals (USA) Inc. On Trokendi XR Patent Litigation 3/7/2017
Teewinot Life Sciences' Subsidiary, Full Spectrum Laboratories, Ltd., Announced Today: Grant Of An Important U.S. Patent With Broad Claims To Biosynthetic Production Of Cannabinoids 3/7/2017
Edwards Lifesciences (EW) Gets Split Decision In UK Heart Valve Patent Spat With Boston Scientific (BSX) 3/3/2017
FUJIFILM Release: The UK High Court Of Justice (Patents) Rules In Fujifilm Kyowa Kirin Biologics' Favor On Rheumatoid Arthritis, Psoriasis And Psoriatic Arthritis Dosing Regimens For Adalimumab Are Obvious And Unpatentable 3/3/2017
Orexo (ORXOF) Commences Patent Infringement Litigation Against Actavis For Their Generic Versions Of Suboxone And Subutex Tablets In The U.S. 3/1/2017
CortControl Granted U.S. Patent For Human Fertility Methodology 3/1/2017
Prima Biomed (PRR.AX) Release: U.S.A. Patent Grants For IMP321 In Cancer 3/1/2017
European Patent Office To Grant CRISPR-Cpf1 Patent To Broad Institute, MIT, And Harvard 2/28/2017
On Generic Drugs, Patent 'Death Squads' And The Oscars 2/28/2017
Eagle Pharma (EGRX) Announces 11th Patent Issued For Bendeka 2/28/2017
Actinium (ATNM.OB) Announces Expansion Of Intellectual Property Portfolio With Notice Of Allowance For U.S. Patent Related To Actimab-A, Actimab-M And The Company’s Technology Platform 2/28/2017
Actinium (ATNM.OB) Announces Expansion Of Intellectual Property Portfolio With Notice Of Allowance For U.S. Patent Related To Actimab-A, Actimab-M And The Company’s Technology Platform 2/28/2017
Lexaria Bioscience Corp. (LXRP) Notice Of Patent In Australia For Cannabinoid Infused Edibles 2/28/2017
Botanix Announces Filing Of New Permetrex Product Patents 2/27/2017
Courtagen Receives Notice Of Allowance For A Genetically Targeted Pain Therapy Patent In The U.S. 2/23/2017
Soligenix (SNGX) Receives European Patent For Formulation Of Synthetic Hypericin To Treat Psoriasis 2/22/2017
Cleveland HeartLab LLC Adds New Patent To Its Extensive Intellectual Property Position For The Myeloperoxidase (MPO) Test, A Powerful Biomarker For Inflammation And Its Role In Major Cardiac Events 2/22/2017
How Much Is a CRISPR Patent License Worth? 2/21/2017
RDD Pharma Announces Patents Granted In Israel And EU 2/21/2017
Eagle Pharma (EGRX) Announces New Patents Issued For Bendeka 2/21/2017
Renova Therapeutics Release: U.S. Patent For Urocortin 2 Gene Constructs Issued 2/21/2017
Symbiotix Biotherapies Announces Issuance Of First Composition Of Matter Patent Covering A Microbiome-Derived Therapeutic Molecule 2/16/2017
CRISPR (CRSP), Intellia, Caribou Biosciences And ERS Genomics Provide Update On CRISPR/Cas9 U.S. Patent Interference Proceedings And Grants Of Corresponding Patents In The U.K. 2/16/2017
Spectro Scientific Wins U.S. Patent For Water Contamination Measurement Method Used In Its FluidScan Handheld Infrared Oil Analyzer 2/16/2017
The Winners And Losers In The CRISPR Patent Fight 2/16/2017
This is Why the Decision on Who Invented CRISPR Matters 2/16/2017
Insmed (INSM) Extends ARIKAYCE Intellectual Property Protection With Issuance Of New U.S. Patent 2/14/2017
ITL Pharma Receives United States Patent Protection For Trithroid Using Sustained Drug Release And Improved Product Stability 2/14/2017
Armetheon Announces Issuance Of A New U.S. Patent For Its Phase 2 Clinical Stage Novel Oral Anti-Arrhythmic Budiodarone 2/13/2017
Onxeo Receives USPTO Notice Of Allowance For A new AsiDNATM-Related Patent, Expanding Its IP Protection In The U.S. 2/13/2017
Koios Receives Favorable Ruling In Challenge To High-Cost Drug’s Patent 2/10/2017
ADM Tronics (ADMT) Launches Major Expansion Of Medical Device Design And Engineering Capabilities 2/10/2017
Replicel Life Sciences Announces European Patents For Its Innovative Dermal Injector Technologies 2/9/2017
SpinalCyte, LLC Announces New U.S. Patent 2/9/2017
Supernus (SUPN) Announces Issuance Of Eighth U.S. Patent Protecting Trokendi XR 2/8/2017
Perrigo (PRGO) Confirms Patent Challenge For Generic Version Of Onexton Gel 2/7/2017